News

Studio City International Holdings Delivers Third Quarter Growth

Studio City International Holdings Delivers Third Quarter Growth

Studio City International Holdings Reports Strong Q3 Performance

Studio City International Holdings Limited (NYSE: MSC), a leading integrated resort, has released its unaudited financial results for the third quarter of 2025. This report highlights notable improvements in revenue and operational efficiency, establishing a positive trajectory for the company amidst industry challenges.

Revenue Growth and Key Performance Metrics

For the third quarter of 2025, Studio City reported total operating revenues of US$182.5 million, a 4% increase from US$174.6 million in the same period of 2024. This revenue growth can be attributed to enhanced performance in mass market operations, particularly in casino contracts.

Gaming Performance Highlights

The Studio City Casino's gross gaming revenue reached US$344.4 million, up from US$335.5 million in the year-ago quarter. Notably, mass market table games experienced a significant drop of US$942.5 million in the third quarter of 2025, compared to US$912.9 million a year prior. The hold percentage also saw an improvement from 30.7% in 2024 to 33.1% in 2025.

Non-Gaming Revenue Insights

Non-gaming revenues totaled US$105.2 million for the third quarter, showing a minor decline from US$107.3 million in 2024. This small dip was overshadowed by the strong performance in the gaming segment, underscoring the importance of a balanced revenue stream for Studio City.

Operating Income and Financial Highlights

Studio City reported an operating income of US$23.9 million, an increase from US$16.0 million in the previous year. Adjusted EBITDA was recorded at US$78.1 million, reflecting a rise from US$68.2 million in Q3 2024, largely due to the increase in revenue from casino contracts.

Net Loss Figures

Despite the positive operational metrics, the net loss attributable to Studio City International Holdings Limited was US$18.6 million, or US$0.10 per American depositary share (ADS), which represents an improvement compared to a net loss of US$21.0 million or US$0.11 per ADS in the same quarter last year.

Impact of Non-Operating Expenses

Non-operating expenses amounted to US$41.1 million during this quarter, with interest expenses comprising US$30.9 million and net foreign exchange losses accounting for US$10.1 million. These operational factors illustrate the complexities in the financial landscape that Studio City navigates.

Strategic Focus Moving Forward

In late 2024, the company strategically repositioned its focus towards premium mass and mass market operations, and this shift has proven beneficial. Furthermore, adjustments in gaming operations, such as the reallocation of assets following the closure of Mocha Kuong Fat, have contributed positively to the overall revenue growth.

Financial Position and Capital Expenditures

As of September 30, 2025, total cash and bank balances stood at US$99.6 million, with total debt decreasing from US$2.16 billion at the end of 2024 to US$2.06 billion by the end of Q3 2025. This reduction indicates improved financial health following strategic repayments of senior notes and other debts.

Conclusion and Outlook

Studio City International Holdings Limited has demonstrated remarkable resilience and adaptability in a competitive market. As the company continues to focus on enhancing its offerings and operational efficiencies, stakeholders can remain optimistic about future financial performance and growth prospects.

Frequently Asked Questions

What are the key highlights of Studio City’s Q3 financial results?

Studio City reported US$182.5 million in operating revenues, up 4% from the previous year, with gross gaming revenues reaching US$344.4 million.

How did Studio City's net loss change compared to last year?

The net loss attributable to Studio City was US$18.6 million, which is an improvement from US$21 million in the previous year.

What were the primary factors influencing revenue growth?

The growth was largely driven by enhanced performance in mass market operations and an increased hold percentage in gaming.

What steps has Studio City taken to improve its operational efficiency?

The company has strategically repositioned focus towards premium mass operations and adjusted its gaming operations, reallocating resources effectively.

What is the current financial position of Studio City International Holdings?

As of September 30, 2025, Studio City has cash balances of US$99.6 million and reduced its total debt to US$2.06 billion.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intestinal Worms: New Science and Old Challenges

Updated Category News Views 48

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Continue Reading
PG&E Breaks Ground with Global Emergency Accreditation

Updated Category News Views 24

Pioneering Emergency Management Standards The landscape of emergency management just got a shakeup, folks. PG&E, an energy utility giant that powers the lives of over 16 million Californians, bagged a distinction that doesn’t roll around every day—indeed, the first of its caliber in the utility sector. Earning accreditation from the big dogs at the Emergency...

Continue Reading
Transforming Healthcare Leadership Through Systemic Change

Updated Category News Views 22

Reframing Physician Leadership for Systemic Transformation Here we go, diving into some serious change-making in the healthcare sphere. If you've ever wandered through a hospital corridor, you've likely felt the tension between docs and the suits. The American Association for Physician Leadership (AAPL) is stirring the pot with a fresh book that might just be the catalyst...

Continue Reading
Blue Moon Metals Scraps Major Acquisition Plan

Updated Category News Views 87

Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...

Continue Reading
Mondel?z Bites into Undercover: Snack Market Impact

Updated Category News Views 46

Snack World Shake-Up: Mondel?z Steps In Ever find yourself browsing the snack aisle, wondering how many brands are duking it out for shelf space? Well, brace yourself, because Mondel?z International — the big cheese in the global snack game — is grabbing a sizeable bite of Undercover Snacks. This is no small news in the land of chocolate-covered and frosted quinoa...

Continue Reading
Endava's Securities Class Action Heats Up Wall Street

Updated Category News Views 13

A Head-Spinning Fall for Endava Endava's recent tumble on the NYSE has investors rubbing their eyes in disbelief. A jaw-dropping 25% slide in share value on September 22, 2026, has everyone scrambling for answers. Looks like some serious skeletons were hiding deep in Endava's closets—management snafus and fuzzy accounting being at the forefront. This debacle has peeled...

Continue Reading
Z Squared Eyes 150 MW Expansion at Arkansas Site

Updated Category News Views 48

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

Continue Reading
Midterms and Retirement: Evaluate Precious Metals

Updated Category News Views 134

Understanding the Financial Climate Amid Midterms Here we go, folks—the red, white, and blue circus we know as the midterms is back in town. And while politicians do their song and dance, you gotta ask yourself if your investments are strong enough to weather any storm those election winds might blow your way. American Independence Gold is waving the flag, telling folks...

Continue Reading
Navigating Holiday Eating with GLP-1 Support

Updated Category News Views 49

GLP-1 Programs: A New Holiday Challenge As if the holidays weren't already a puzzle with family dinners and over-the-top office parties, folks on a GLP-1 program have another set of questions, like navigating a buffet without guilt. Ain’t no sugarcoating it—December throws every routine straight out the window. It's not just about what pie to eat, but how to keep your...

Continue Reading
Viatris Bids for Pacira: Strategic Healthcare Move

Updated Category News Views 51

Viatris Takes Strategic Step With Pacira Acquisition You ever notice how in the pharmaceutical games, it's not always the pills but the strategic moves that make the money? Viatris Inc., the global healthcare heavyweight, has just rolled the dice. They've initiated a tender offer to acquire Pacira BioSciences, a player in the non-opioid pain management market. Here's the...

Continue Reading

Top 5 Most Recently Viewed Articles

Matthews International Prepares for Q2 Fiscal 2025 Earnings Call

Updated Category News Views 340

Matthews International's Upcoming Earnings Release PITTSBURGH — Matthews International Corporation (Nasdaq: MATW) has exciting plans to unveil its financial results for the second quarter of fiscal year 2025. The earnings announcement is scheduled for Wednesday after the market closes. This is an important time for investors, as it provides insights into the company's...

Continue Reading
Investigation Launched for Proficient Auto Logistics, Inc.

Updated Category News Views 291

Overview of Proficient Auto Logistics, Inc. Proficient Auto Logistics, Inc. (NASDAQ: PAL) has come under scrutiny as Pomerantz LLP initiates an investigation into the company's financial practices. The firm is exploring whether Proficient Auto and its leadership have engaged in securities fraud or any unethical business methods. Details of the Investigation The ongoing...

Continue Reading
Abacus Global Management Sees Revenue Surge with $44.1M Q1

Updated Category News Views 124

Abacus Global Management Reports Exceptional Q1 Performance Abacus Global Management, Inc. (NASDAQ: ABL), a prominent player in the alternative asset management sector, has shared impressive financial results for the first quarter of 2025. The company's total revenue exceeded expectations as it reached $44.1 million, effectively doubling from the same quarter of the...

Continue Reading
Korro Bio's Upcoming Conferences: Innovations in RNA Editing

Updated Category News Views 242

Korro Bio's Upcoming Conferences Korro Bio, Inc. (NASDAQ: KRRO) is set to engage with investors and the wider scientific community during several upcoming conferences this September. These engagements are pivotal for displaying its advancements in RNA editing technology, a focus of the company. Citi's Biopharma Conference Dr. Ram Aiyar, the Chief Executive Officer of...

Continue Reading
Qualcomm’s Impressive Q3 Financial Results Reveal Growth

Updated Category News Views 111

Qualcomm's Strong Q3 Performance Qualcomm Inc (NASDAQ: QCOM) has showcased outstanding financial results for the third quarter, demonstrating resilience and growth in a competitive market. The company reported a revenue of $10.365 billion, reflecting a 10% increase compared to the previous year and exceeding analysts' estimates of $10.333 billion. Key Financial Highlights...

Continue Reading